US$ 20.55
fda approval bpc-157 status Understanding the Legal Risks of and Other Unapproved Peptides – Holt Law FDA Peptide Reclassification 2026 |
Description
Cisplatin-incorporated polymeric micelles reducing nephrotoxicity, while maintaining antitumor activity

TB-500 works systemically, so its injection location does not affect which tissue it reaches
10.1038/s42003-020-0957-6 171 WenC.LiF.ZhangL.DuanY.GuoQ.WangW.et al

After reconstitution: Reconstitute the powder using sterile, bacteriostatic water in a controlled laboratory setting, following appropriate biosafety procedures
